EN | |

MILESTONES & AWARDS

Uni-Bio Science Group always keeps its own vision and mission based on adjusted real value.

Strategic Partnership formed between Uni-Bio, Sinopharm Weiqida and Suzhou Yingli for Acarbose development

Uni-Bio Science Group successfully acquire capital injection by fund with state-owned background

Cooperation Agreement between Uni-Bio and Loymed Pharma

Uni-PTH accepted for CFDA review

Uni-Bio Science and Beijing Baiao Pharmaceutical entered into strategic cooperation agreement on the development of oral antidiabetic drugs, Acarbose tablets

HeungKong Great Health Fund I inject HKD$120 million into Uni-Bio Science, and becomes its strategic shareholder

Launch of Mitiglinide, oral ant-diabetic drug under the registered brand name 博康泰®(Bokangtai)

Uni-Bio Science in Multiple Drug Co-development Deal with Beijing Sun-Novo

Uni-Bio Science forges Strategic Alliance with China Resource Zizhu for GeneSoft®

Uni-Bio Science acquires exclusive global rights to Type 2 diabetes drug Mitiglinide from Jiangsu Hansoh Pharmaceuticals

Uni-Bio Science receives newest cCMP certification for its manufacturing line in Beijing

Uni-Bio Science announces positive phase lll results forUni-E4 in Type 2 diabetes

Uni-Bio Science forms strategic partnership with Korean pharmaceutical company Samil Pharmaceuticals

Uni-Bio Science receives newest cCMP certification for its manufacturing line in Shenzhen

Received national grants for Uni-E4 as key innovative project

Shenzhen Watsin becomes a wholly owned subsidiary of Uni-Bio Science Group

Received provincial grant from Guangzhou province in recognition of Uni-PTH and Uni-E4 as key innovative projects.

Beijing Genetech becomes wholly owned subsidiary of Uni-Bio Science Group.

Uni-Bio Science Group lists on Hong Kong Stock Exchange

Corporate Awards

Awarded the ”Hong Kong Listed Company of Golden Hong Kong Stocks Award 2017”

2015 Hong Kong Business High Flyer Awards Healthcare solutions

This award recognises 
the company’s efforts in innovation, demonstrating its commitment to excellence in both operations and customer focus

2015 Hong Kong Business Listed Companies Awards

This award recognises 
the company’s focus in innovation within its industry

2015 Hong Kong Investor Relations Association Winner Best IR small cap

This award recognises 
the company’s focus on good investor relations practices and corporate governance